[The combined effect of anti-tumor agents with caffeine or calcium channel blockers on sarcoma cells by clonogenic assay].
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D002110:Caffeine / Q000494:pharmacology*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D003114:Colony-Forming Units Assay; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D012516:Osteosarcoma / Q000473:pathology; D012509:Sarcoma / Q000473:pathology*; D014410:Tumor Stem Cell Assay; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D002110:Caffeine; D014700:Verapamil